TY - JOUR T1 - Perspectives on Cutting-Edge Clinical Trials JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1027 LP - 1030 DO - 10.2967/jnumed.121.262681 VL - 62 IS - 8 AU - Michael S. Hofman AU - Jérémie Calais AU - Johannes Czernin Y1 - 2021/08/01 UR - http://jnm.snmjournals.org/content/62/8/1027.abstract N2 - ER -